Medical network on January 3 - in the top ranking of global pharmaceutical company of the past, very rare, even without a drug firms in China, the Indian sun pharmaceutical has for several years on the list. Everyone is looking forward to, when the list can have local drug firms in China!
Today is the first day of 2017, we also bring you a New Year's surprise, this time, our country's local drug firms on the list at last!
Previously, Informa Pharma Intelligence has released the 2016 top 100 global pharmaceutical companies, according to the 2015 sales for sorting standard, ranking the top of the list are remained, novartis, Pfizer, roche, the three big pharmaceutical giant situation of the three pillars of for many years.
Among them, it is worth noting that the three Chinese native medicine companies on the list, respectively is the sea is drug, drug group, Shanghai pharma, 60, 78, 92 respectively.
Before this, make Chinese people heart, is not in the list of Chinese native medicine companies, while the Indian sun pharmaceutical consecutive years ranked list. The varieties and the company's most profitable, is our country people's heart of imatinib mesylate tablets, which is the familiar "gleevec" generic drugs.
In terms of pharmaceutical innovation level, our country on the whole, also a weakness. First in terms of r&d can glimpse. It is reported that the United States each year for new drug research and development of more than $100 billion. A continuing generous multinational drug companies in r&d. Multinational pharmaceutical companies most r&d spending for the annual sales revenue of 15% ~ 15%. Even with predominantly generic Indian pharmaceutical company, the proportion of r&d spending was close to 10% of annual sales revenue.
For local drug firms in our country, the less enterprise r&d, innovation ability is weak, is a problem in industry development. On the product structure, for many years, our country give priority to with generic drug firms, and majority is low level repeated change dosage form drugs, there is very little innovation. And multinational pharmaceutical companies in China for high-end patent medicine almost monopolized the market as a whole.
Now, in a multinational drug companies stepping up to China at the same time, some powerful local drug firms are holding overseas, through the active overseas investment layout to take in the future international dispute. At the same time, explore the direction of the new drug research and development, constantly open up new drug research and development, enhance the economic power, strengthening the management of research and development. We look forward to, the Chinese native medicine companies one day, also will appear with huawei enterprise was born, famous all over the world!
|
